Effectiveness of a Short and Telematic Version of Cognitive-behavioral Treatment for Borderline Personality Disorder
Condition:   Borderline Personality Disorder Interventions:   Behavioral: Dialectical Behavior Therapy -3-months;   Behavioral: Dialectical Behavior Therapy -6-months Sponsors:   Pontificia Universidad Catolica de Chile;   University Diego Portales Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2021 Category: Research Source Type: clinical trials

ORYZON Enrolls First Patient in PORTICO, a Phase IIb Clinical Trial with Vafidemstat in Borderline Personality Disorder
MADRID, SPAIN and CAMBRIDGE, MA, UNITED STATES, March 29th, 2021 - Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - March 29, 2021 Category: Pharmaceuticals Source Type: clinical trials